Source:http://linkedlifedata.com/resource/pubmed/id/11311965
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-4-20
|
pubmed:abstractText |
This study was performed to clarify if diabetic complications are associated with liver enzyme activities in type 1 diabetic outpatients. Elevated activities of serum aminotransferases are a common sign of liver disease and are observed more frequently among people with diabetes than in the general population. Many studies have shown an association between specific diabetic complications and disturbances in various tissues, such as diabetic nephropathy and cardiovascular diseases, but only limited data are available on the possible association between diabetic complications and liver function. We studied 28 patients with type 1 diabetes. Mean age was 43.4+/-9.5 (S.D.), and duration of diabetes 25.2+/-9.7. Limited joint mobility (LJM) was assessed by the Rosenbloom's method. Background and proliferative retinopathy, and peripheral symmetrical polyneuropathy were also assessed. Activities of alanine amino transferase (ALT), gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) in serum were determined. The metabolic control of the diabetes was evaluated by the glycosylated haemoglobin A(1c) (HbA(1c)) level and lipid values were also measured. ALT activity was associated with LJM (P<0.01) and with neuropathy (P<0.01). Association between GGT activity and LJM (P<0.01) and neuropathy (P<0.01) were also found. GGT activity was also associated with the severity of retinopathy (P<0.01). None of these associations was explained by confounding effects of diabetes duration, age, body mass index (BMI), HbA(1c) or alcohol consumption. In conclusion, diabetic complications such as LJM, retinopathy and neuropathy are associated with liver enzyme activities independent of alcohol consumption, BMI and metabolic control of diabetes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0168-8227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11311965-Adult,
pubmed-meshheading:11311965-Alanine Transaminase,
pubmed-meshheading:11311965-Alkaline Phosphatase,
pubmed-meshheading:11311965-Diabetes Mellitus, Type 1,
pubmed-meshheading:11311965-Diabetic Neuropathies,
pubmed-meshheading:11311965-Diabetic Retinopathy,
pubmed-meshheading:11311965-Humans,
pubmed-meshheading:11311965-Joint Diseases,
pubmed-meshheading:11311965-Liver,
pubmed-meshheading:11311965-Male,
pubmed-meshheading:11311965-Middle Aged,
pubmed-meshheading:11311965-gamma-Glutamyltransferase
|
pubmed:year |
2001
|
pubmed:articleTitle |
Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes.
|
pubmed:affiliation |
Department of Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland. perttu.arkkila@hus.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|